Form 8-K - Current report:
SEC Accession No. 0000950170-22-026232
Filing Date
2022-12-08
Accepted
2022-12-08 16:09:27
Documents
13
Period of Report
2022-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20221202.htm   iXBRL 8-K 60501
2 EX-10.1 acet-ex10_1.htm EX-10.1 67557
  Complete submission text file 0000950170-22-026232.txt   258872

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20221202.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20221202_pre.xml EX-101.PRE 10289
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20221202_lab.xml EX-101.LAB 14018
7 EXTRACTED XBRL INSTANCE DOCUMENT acet-20221202_htm.xml XML 4933
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 221452495
SIC: 2834 Pharmaceutical Preparations